Catheter Precision (VTAK) announced that it has entered into securities purchase agreements with institutional investors for a $1.5M private placement equity financing and the acquisition of certain promissory notes of QHSLab. Ladenburg Thalmann & Co. acted as exclusive placement agent for these transactions.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Finalizes Strategic Cardiac Acquisition
- Catheter Precision completes acquisition of Cardionomic heart failure assets
- Catheter Precision announces clinical data about VIVO to be presented
- Catheter Precision to acquire assets of Cardionomic related to CPNS system
- Catheter Precision receives notice of first patent allowance in US for LockeT